Genetic testing can provide important information about genetic changes associated with cancer. In personalized cancer treatment, these results may help healthcare professionals understand tumor characteristics, identify potentially useful treatment options, and estimate certain inherited risks about their cancer care with guidance from qualified healthcare professionals.
Cancer treatment has increasingly moved toward approaches that consider the biological characteristics of an individual’s cancer. Genetic testing is one important part of this approach. It can examine genetic changes in tumor cells or inherited DNA to provide information that may help healthcare professionals understand a cancer more precisely. The results can sometimes influence treatment decisions, identify eligibility for certain targeted therapies, or provide information about inherited cancer risks. Genetic testing does not replace standard diagnosis or medical evaluation, but it can add valuable information when used appropriately.
Genetic testing involves analyzing DNA to identify specific changes, often called mutations or genetic variants. In cancer care, testing may focus on the genetic material within tumor cells or on inherited DNA from normal cells. These two approaches provide different types of information and should not be considered interchangeable.
Tumor testing, sometimes called somatic testing, looks for genetic changes that developed in cancer cells. These changes may influence how a tumor grows or responds to particular treatments. Germline testing examines inherited genetic changes that may be present throughout the body and can sometimes indicate an increased risk of developing certain cancers.
Genetic testing may help healthcare professionals:
The decision to undergo testing depends on factors such as cancer type, stage, family history, previous treatment, and available testing methods. Results should be interpreted by qualified healthcare professionals because not every genetic change has a known effect on cancer or treatment.
Personalized cancer treatment aims to match medical decisions with the characteristics of a person's cancer. Genetic test results can contribute to this process by identifying alterations that may be associated with specific therapies. For example, some cancers contain genetic changes that can make certain targeted medicines more relevant than treatments selected solely according to the cancer's location.
However, a genetic finding does not automatically mean that a particular treatment will work. Treatment decisions usually consider multiple factors, including the cancer type, disease stage, overall health, previous treatments, biomarker results, and clinical evidence.
Genetic testing can contribute to personalized treatment by helping healthcare teams:
Test results can also be classified in different ways, such as pathogenic, likely pathogenic, benign, likely benign, or uncertain. A variant of uncertain significance does not necessarily indicate that a person has an increased cancer risk or that a specific treatment should be used. Professional interpretation is therefore important.
genetic testing is an increasingly useful component of personalized cancer treatment because it can provide detailed information about genetic characteristics associated with tumors and inherited cancer risk. Its value depends on appropriate test selection, accurate interpretation, and integration with other clinical information. Patients considering genetic testing can discuss its potential benefits, limitations, and implications with their healthcare team or a qualified genetic counselor. Genetic testing is an informational tool that supports medical decision making rather than a standalone method for diagnosing or treating cancer.